Suvorexant
Records for this ingredient, by country (identity only).
ATC N05CJ01 · 4 markets · 14 records
US 4 records · 4 shown of 4
AU 3 records · 2 shown of 2
- 20 mgtabletBELSOMRA suvorexant 15mg tablet blister pack
- 15 mgtabletBELSOMRA suvorexant 15mg tablet blister pack
1 records · 0 manufacturers 1 registros · 0 fabricantes 1 个记录 · 0 个厂家 1 個記錄 · 0 個廠商
With a brand name Con nombre comercial 有商品名 有商品名BELSOMRA ×2
Full list in the data package Lista completa en el paquete de datos 完整清单见数据包 完整清單見資料包
JP 3 records · 3 shown of 3
- 20 mgtabletベルソムラ錠10mg
- 15 mgtabletベルソムラ錠10mg
- 10 mgtabletベルソムラ錠10mg
| Strength / form / release | US | AU | JP |
|---|---|---|---|
| 20 mg tablet | BELSOMRA | BELSOMRA suvorexant 15mg tablet blister pack | ベルソムラ錠10mg |
| 15 mg tablet | BELSOMRA | BELSOMRA suvorexant 15mg tablet blister pack | ベルソムラ錠10mg |
| 10 mg tablet | BELSOMRA | ベルソムラ錠10mg | |
| 5 mg tablet | BELSOMRA | ||
unknown | BELSOMRA |
Scroll horizontally for more markets →
Each country column shows the locally registered trade names — not translations.
“not disclosed” means the source does not publish the strength — it does not mean the product has none.
Australia ARTG data has no registration-status column, so status is shown as unknown; being on the register does not mean currently marketed.
The same ingredient can carry completely different
brand names in different countries, and the same name can point to a different ingredient.
Listed by country — not interchangeable.
Discontinued, withdrawn or unverified-status products are hidden by default; Hong Kong and Australia records are shown as exceptions.